Will Nasdaq announce Rocket Lab as a Nasdaq-100 constituent by 3 December 2026?
Avaldatud 2026-10-04 — 60 päeva enne tähtaega, väidetud enne tulemuse selgumist.
The Nasdaq-100 is a stock market index composed of 100 of the largest non-financial companies listed on the Nasdaq stock exchange. Index providers periodically review and adjust their constituent lists to reflect changes in market capitalization and eligibility criteria.
Väide
By 2026-12-03, Nasdaq will not have published any formal announcement naming Rocket Lab as a new Nasdaq-100 constituent.
Põhjendusahel
- Linchpin: Index provider guidance will be issued without further governance-driven delay, enabling formal index classification (underpins 60 predictions)
- Rocket Lab's Nasdaq-100 candidacy is the direct test: if Nasdaq publishes no formal announcement naming RKLB as a new constituent by 3 December, the governance/legal-review failure mode is confirmed and the assumption breaks for all 60 predictions riding on timely index classification.
Tõendid seni
0 kinnitavat · 0 ümberlükkavat signaali · 0 kinnitust · 2 murtud eeldust. Tõendid ise on osa täisdossiest.
Tõenäosuse ajalugu
Uuendatud 1 kord alates lisamisest (viimati 2026-10-04) — 82% alguses → 82% täna.
Mida jälgida
- juhtnäitaja MSCI publishes a public document detailing index methodology failures or exclusion decisions for specific tickers.
- juhtnäitaja Cboe Global Markets publishes a press release or files a Form 8-K with the SEC announcing a delay to the implementation of its index governance changes.
- juhtnäitaja Cboe Global Markets issues a public statement or media release explicitly citing legal or governance review as the reason for postponing the index classification framework.
Selle ennustuse taga olev täisdossier — tõendite jälg, riskianalüüs, rahastamisstsenaariumid — on saadaval soovi korral: [email protected].
Tõenäosused on kalibreeritud süsteemi enda lahendatud ajaloo põhjal; pärast tähtaega tulemus lahendatakse ja auditeeritakse — kaasa arvatud need, milles me eksisime. Miski sellel lehel ei ole investeerimisnõuanne.